SmallCapIntel Stock Signal
$APUS
APUS
Live signal history, momentum scoring, market alert activity, and recent catalysts.
Latest Signal
Momentum Surge
Grade
Score
71/100
Change
+47.36%
Previous Volume
87.9M
Signal Strength
Moderate Conviction
71%
Intelligence Summary
Why this signal matters
APUS triggered a B-rated Momentum Surge after moving +47.36%. The stock is currently priced at $7.25, with prior-session volume of 87.9M. SmallCapIntel assigned a 71/100 score based on price momentum, liquidity quality, and trader-friendly price-zone behavior.
Signal Breakdown
Score Components
Recent Catalysts
News and market-moving context
2 items found
IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc.
GlobeNewswire Inc. · 9/18/2026, 6:00:00 PM
Apimeds Pharmaceuticals US (NYSE American: APUS), a clinical-stage biopharmaceutical company developing non-opioid therapies for pain management, has engaged IBN to enhance its corporate communications strategy. The company's subsidiary, MindWave Innovations, is developing blockchain-based institutional digital asset infrastructure combining custody, reporting, and portfolio management for Bitcoin reserves and digital asset participation.
APUS Investors Have Opportunity to Join Apimeds Pharmaceuticals US, Inc. Fraud Investigation with the Schall Law Firm
GlobeNewswire Inc. · 4/27/2026, 12:12:00 AM
The Schall Law Firm is investigating Apimeds Pharmaceuticals US, Inc. (APUS), Elite Express Holding Inc. (ETS), and Decent Holding Inc. (DXST) for potential securities law violations, including allegations of false statements and failure to disclose material information to investors. Affected shareholders are encouraged to participate in the investigation.
Bull Case
Why traders may watch it
Risk Factors
What could go wrong
Signal History
2 total alerts logged for $APUS.
Momentum Surge
9/27/2026, 1:38:54 PM
Momentum Surge
9/26/2026, 1:38:54 PM
Market data is informational only. Not investment advice.